The Federal Court has this week ruledi that the encapsulation in Australia of imported fish oil and vitamin D would no longer be able to be labelled as ‘Made in Australia’. In response, Mr Carl Gibson, CEO of Complementary Medicines Australia (CMA), has said: “The outcome of the court case underlines how Australian companies are being caught up as an unintended consequence of recent law reforms and being negatively impacted by the current application of the new ACCC Country of Origin Guideline for complementary healthcare products.” Read more here